(Q38065062)

28 August 2017

1 reference

title

Clinical applications for microRNAs in cancer (English)

1 reference

28 August 2017

1 reference

2

C M Croce

1 reference

28 August 2017

S P Nana-Sinkam

1

1 reference

PubMed ID

23212103

28 August 2017

language of work or name

English

0 references

publication date

5 December 2012

1 reference

Clinical Pharmacology & Therapeutics

28 August 2017

1 reference

28 August 2017

93

1 reference

28 August 2017

1

1 reference

28 August 2017

98-104

1 reference

MicroRNAs and other tiny endogenous RNAs in C. elegans

28 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Causes and consequences of microRNA dysregulation in cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

LNA-mediated microRNA silencing in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

miR-34 - a microRNA replacement therapy is headed to the clinic

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Dicer, Drosha, and outcomes in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA profiling: approaches and considerations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Clinical outcome prediction by microRNAs in human cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNAs are exported from malignant cells in customized particles

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Characterization of extracellular circulating microRNA

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA expression profiles classify human cancers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Reprogramming of miRNA networks in cancer and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Discovery of multi-dimensional modules by integrative analysis of cancer genomic data

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

RAS is regulated by the let-7 microRNA family

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

The let-7 microRNA represses cell proliferation pathways in human cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Regression of murine lung tumors by the let-7 microRNA

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Frequent downregulation of miR-34 family in human ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

miR-34a repression of SIRT1 regulates apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Intact p53-dependent responses in miR-34-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

mir-29 regulates Mcl-1 protein expression and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNAs modulate the chemosensitivity of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

RNAi therapeutics: principles, prospects and challenges

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Silencing of microRNA families by seed-targeting tiny LNAs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Suppression of non-small cell lung tumor development by the let-7 microRNA family

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

MicroRNA delivery by cationic lipoplexes for lung cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.192

7 January 2021

Identifiers

DOI

10.1038/CLPT.2012.192

1 reference

28 August 2017

1 reference

PubMed ID

23212103